60.70EUR+1.73%Mkt Cap: —P/E: 18.271d ago
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, B…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap—
Enterprise Value3.22B $
Revenue (TTM)840.27M $
Gross Profit543.93M $
Net Income (TTM)201.28M $
Revenue/Share16.43 USD
Last Price60.70 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.5K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINES0157261019
Valuation
P/E (Trailing)18.27
P/E (Forward)—
PEG—
EV/EBITDA16.86
EV/Revenue3.84
P/S—
P/B4.24
EPS (TTM)3.32
EPS (Forward)—
52W Range
57.3594% of range60.90
52W High60.90 EUR
52W Low57.35 EUR
Profitability
Gross Margin64.73%
Oper. Margin9.42%
EBITDA Margin22.76%
Profit Margin23.96%
ROE28.65%
ROA9.44%
Growth
Revenue Growth20.00%
Earnings Growth246.70%
Cash Flow & Leverage
Operating CF275.34M $
CapEx (TTM)—
FCF Margin21.67%
FCF Yield—
Net Debt-22.15M $
Net Debt/EBITDA-0.12
Balance Sheet
Debt/Equity15.02
Current Ratio2.05
Quick Ratio1.04
Book Value/Sh13.70 EUR
Cash/Share2.504 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.9590 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.49.31M
Float16.20M
Insiders68.20%
Institutions17.81%
Technical
SMA 5067.54 (-10.1%)
SMA 20053.85 (+12.7%)
Beta0.23
S&P 52W Chg20.80%
Avg Vol (30d)3.75K
Avg Vol (10d)10.37K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—